Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023 - Seite 2

Covalon’s IV Clear dressing is the world’s only dual antimicrobial silicone adhesive vascular access dressing. Its features include:

• Chlorhexidine and silver embedded into the entire surface of the dressing provide broad spectrum protection.
• Silicone adhesive helps to maintain skin integrity and keeps patients comfortable.
• Complete transparency allows for visualization and easy daily assessment of the site and surrounding skin.

Covalon’s other IV-related solutions include:

• CovaClear IV – utilizes soft silicone adhesive technology to help protect patients from skin injuries, but does not incorporate antimicrobials, for use with patients who either don't require or cannot tolerate antimicrobials.

• VALGuard - a transparent, environmental barrier designed to protect catheter hubs and line connections from external contaminants and gross contamination, including body fluids and other secretions. It incorporates a quick-release pull strip for fast access to infusion hubs and for easy removal.

The 2023 Annual Oley Foundation Conference

The Oley Foundation aims to enrich the lives of those living with home intravenous (IV) nutrition or tube feeding through advocacy, education, community, and innovation. The conference brings together clinicians, patients, and industry to facilitate knowledge sharing on tube feeding and IV nutrition. Covalon representatives will be available to meet with participants on site. To make an appointment, please contact Ron Hebert, SVP Marketing, at [e-mail].

Conference details

Dates: Tuesday, June 27 – Friday, June 30, 2023

Venue: Hyatt Regency St. Louis at The Arch (315 Chestnut Street, St. Louis, Missouri 63102)

Registration: https://oley.org/event/Oley2023

For healthcare providers who are not able to attend the conference but are interested in learning more about Covalon’s solutions, visit www.covalon.com or follow Covalon on LinkedIn, Facebook, Instagram or Twitter.

About Covalon

Covalon Technologies Ltd. is a patient-driven medical device company, built on the relentless pursuit to help the most vulnerable patients have a better chance at healing. Through a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, we offer innovative, gentler, and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon’s name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF. To learn more about Covalon, visit our website at www.covalon.com.